Cadence Health Company Profile
✉ Email this page to a colleague
What is the competitive landscape for CADENCE HEALTH, and what generic and branded alternatives to CADENCE HEALTH drugs are available?
CADENCE HEALTH has two approved drugs.
Drugs and US Patents for Cadence Health
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cadence Health | LO/OVRAL | ethinyl estradiol; norgestrel | TABLET;ORAL-21 | 017612-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Cadence Health | ALESSE | ethinyl estradiol; levonorgestrel | TABLET;ORAL-28 | 020683-002 | Mar 27, 1997 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Cadence Health | ALESSE | ethinyl estradiol; levonorgestrel | TABLET;ORAL-21 | 020683-001 | Mar 27, 1997 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Cadence Health
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Cadence Health | LO/OVRAL | ethinyl estradiol; norgestrel | TABLET;ORAL-21 | 017612-001 | Approved Prior to Jan 1, 1982 | 3,666,858 | ⤷ Sign Up |
Cadence Health | LO/OVRAL | ethinyl estradiol; norgestrel | TABLET;ORAL-21 | 017612-001 | Approved Prior to Jan 1, 1982 | 3,959,322 | ⤷ Sign Up |
Cadence Health | LO/OVRAL | ethinyl estradiol; norgestrel | TABLET;ORAL-21 | 017612-001 | Approved Prior to Jan 1, 1982 | 3,850,911 | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.